| Drug Name: | Pentazocine (359-83-1) |
|---|---|
| PubChem ID: | 12259685 |
| SMILES: | C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O |
| InchiKey: | VOKSWYLNZZRQPF-CCKFTAQKSA-N |
| Therapeutic Category: | Adjuvants, Analgesics, Central Nervous System Agents, Central Nervous System Depressants, Narcotic Antagonists, Narcotics, Peripheral Nervous System Agents, Sensory System Agents |
| Molecular Weight (dalton) | : | 285.431 |
| LogP | : | 3.8826 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 23.47 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Acetylsalicylic acid (50-78-2) | Renal Papillary Necrosis | Antagonistic | Pentazocine-induced reduction in blood flow through the kidney potentiated the adverse effects of chronic aspirin use | Renal papillary necrosis caused by long-term ingestion of pentazocine and aspirin |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category